Fibrates and HDL cholesterol.
Murphy
M J
MJ
Packard
C J
CJ
O'Reilly
D S
DS
D016632:Apolipoprotein A-I / Q000187:drug effects / Q000378:metabolism; D008076:Cholesterol, HDL / Q000378:metabolism*; D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D011345:Fenofibrate / Q000627:therapeutic use*; D058607:Fibric Acids; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007009:Hypolipoproteinemias / Q000139:chemically induced*; D008875:Middle Aged; D011341:Probucol / Q000627:therapeutic use
D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate; D011341:Probucol; D011345:Fenofibrate